Commuters walk past the Bombay Stock Exchange building in Mumbai. Reuters
Major Indian indices − Sensex and Nifty − closed at their highest-ever on Tuesday riding strong and sustained foreign fund inflows and bets of yet another rate cut over a near-normal monsoon forecast. Both indices touched their all-time highs − Sensex at 39,364.34 and Nifty 11,810.95 − during the early trade and mostly held on to the gains
Sensex and Nifty ended lower on Thursday after advancing for four consecutive sessions as investors took to profit booking. Investors also treaded with caution ahead of Q4 results from index heavyweight Reliance Industries. Jet Airways was in the spotlight throughout the day over its steep fall.
Investors on Tuesday traded with caution anticipating a further rise in the international oil prices, and conclusion of the third and largest phase of the general elections. Sensex ended 80 points lower after a range-bound movement throughout the day’s trade.
The contribution of core digital sectors like information technology-business process management (IT-BPM), digital communications, and electronics manufacturing to India’s gross domestic product (GDP) may increase from seven per cent in 2017-18 to eight to 10 per cent in 2025, says a new report from McKinsey Global Institute.
A recently signed agreement between Al Ain Cement Factory, a subsidiary of Arkan Building Materials Co, a leading manufacturer of building materials in UAE, and the National Cement Factory (NCF)
The Indian equity markets is set to face another volatile week ahead, as the ongoing flight of foreign funds is expected to continue on the back of latest taxation surcharge on the super rich category along with subdued quarterly earning numbers.
Government initiatives have stimulated the residential and commercial sectors, whilst the country’s hospitality and retail segments continue to benefit from diversification efforts - according to the H1, 2019 Riyadh Market Snapshot by global real estate
Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters.